Adir Et Compagnie

Other

Gerard Adam

Pierre Renard

Patrick Depreux

Beatrice Guardiola

Daniel H Caignard

Daniel Lesieur

Daniel-Henri Caignard

Said Yous

Gerald Guillaumet

Isabelle Lesieur

Beatrice Guardiola-Lemaitre

Bruno Pfeiffer

Guillaume Le Baut

Tchao Podona

Gerard Coudert

Sylvie Robert-Piessard

Thierry Taverne

Jean-Francois Renaud De La Faverie

Michelle Devissaguet

Jean-Guy Bizot-Espiard

Jean-Michel Robert

Jean-Paul Babingui

Daniel Henri-Caignard

Marie-Claire Rettori

Jean Andrieux

Jacqueline Courant

Ange Mouithys-Mickalad

Paul J Caubere

Michel Langlois

Max Robba

Christine Flouzat

Henri P Husson

Catherine Caubere

Valerie Thiery

Odile Rideau

Brigitte Jamart-Gregoire

Jean C Quirion

Martine Bonin

Ousmane Diouf

Philippe Delagrange

Jean-Claude J Souvie

Marie-Claude Viaud

Camille-Georges Wermuth

Sylvain Rault

Jean-Jacques Bourguignon

Claude Fugier

Hamid Ait Mansour

Muriel Duflos

Michel Boulouard

Genevieve Baziard-Mouysset

Dominique Manechez

Marc Payard

Francedillaois Lefoulon

Laurence Savelon

Marie P Foloppe

Lucien Welin

Panayota Pavli

Vincent Galet

Catherine Nguyen

Marie-Pierre Vaccher

Yvette Morot-Gaudry

Maurice Israel

Michel Gaudry

Habib Abdellaoui

Jean-Francois R De La Faverie

jean-Francois Renaud De La Faverle

Jean-Guy Bizot Espiard

Marie-Renee Nourrisson

Gilbert De Saqui-Sannes

Isabelle Morin

A compound selected from those of formula (I): ##STR1## where m is equal to 0 or 1 and Het, A, X, R,R.sub.1, R.sub.2, R.sub.3, R.sub.4 and the ring ##STR2## are defined in the description, and a medicinal product comprising the same for treating an inflammatory disorder.

N-pyridyl carboxamides and derivatives

The invention relates to a compound selected from those of formula (I): ##STR1## wherein R.sub.1, W and Y are as defined in the description, its geometric and/or optical isomers, and its pharmaceutically-acceptable addition salts with an acid or a base useful as analgesies.

1,3-dihydro-2H-pyrrolo�2,3-b!pyridin-2-one compounds

A compound selected from those of formula (I): ##STR1## where m is equal to 0 or 1 and

A compound which is selected from those of formula (I) : ##STR1## in which A, R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5 and R.sub.6 are as defined in the description, its optical isomers, and its addition salts thereof with a pharmaceutically-acceptable acid or base, and medicinal products containing the same which are useful for treating a disorder of the melatoninergic system.

Arylalkyl(thio)amides

The invention relates to a compound selected from those of formula (I): ##STR1## in which R.sub.1, R.sub.2, R.sub.3, X and n are as defined in the description, the optical isomers thereof, and the addition salts thereof with a pharmaceutically acceptable acid or base and medicinal product containing the same, useful for treating a mammal afflicted with a pathology associated with the sigma receptors.

Aminoalkyl benzoxazolinones and benzothiazolinones

A compound selected from those of formula (I): ##STR1## in which R.sub.1, R.sub.2, R.sub.3 and A are as defined in the description.

(Thia) cycloalkyl[B]indole compounds as anti-inflammatory agents

The invention relates to a compound selected from those of formula (I): ##STR1## in which R, R.sub.1, R.sub.2 and R.sub.3 are as defined herein for use in the treatment of a disorder of the melatoninergic system.

Trisubstituted naphthylalkylamides for disorders of the melatoninergic

The invention relates to a compound selected from those of formula (I): ##STR1## wherein Ar, n, B and A are as defined in the description, to their optical isomers, and to their addition salts there of with a pharmaceutically-acceptable acid or base. The compounds are useful for treating or preventing anxiety and depression.

(Aryl(alkyl)carbonyl)-heterocyclic compounds and their use in the

The invention relates to compounds of the general formula (I): ##STR1## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6 and Z are as defined in the description, their optical isomers and their addition salts with a pharmaceutically-acceptable acid or base and medicaments containing the same, useful in the treatment and prevention of stress, anxiety, and related ailments.

New aminoalkylchromones, processes for the preparation thereof

The invention relates to a compound selected from those of formula (I): ##STR1## in which R.sub.1, R.sub.2, R.sub.3 and A are as defined in the description, and medicinal product containing the same in order to treat a mammal afflicted with a peroxydation phenomenom.

(Thia)cycloalkyl[B]indoles

Compounds of the general formula: ##STR1## wherein m, X, Y, A, R.sub.2 and R.sub.3 are defined in the description.

.alpha.-amino acid compounds

A compound which is selected from those of formula (I): ##STR1## in which A, R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5 and R.sub.6 are as defined in the description, its optical isomers, and its addition salts thereof with a pharmaceutically-acceptable acid or base, and medicinal products containing the same which are useful for treating a disorder of the melatoninergic system.

Arylalkyl (thio) amides

A compound selected from those of formula (I): ##STR1## in which the meanings of R, R.sub.1, R.sub.2 and X are as defined in the specification, and

Naphthylethylureas and naphthylethylthioureas

Growing community of inventors

Le Mesnil Le Roi, France

Gerard Adam